Demo Sign up Log In

Inhibikase Therapeutics Inc (IKT)

EV/EBITDA

-3.21×

TTM · Retrieved: Oct 22, 2026

IKT EV/EBITDA

Current (TTM)-3.21×retrievedOct 22, 2026

Current (TTM)-3.21×retrievedOct 22, 2026

IKT Quarterly EV/EBITDA (0.00× → -16.50×)

Latest values, visible window

High-resolution chart · PNG

IKT ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc EV/EBITDA — Quarterly
Period ending	EV/EBITDA
Jun 30, 2026	-16.4958×
Mar 31, 2026	-14.6453×
Dec 31, 2025	-4.1002×
Sep 30, 2025	-8.1294×
Jun 30, 2025	-8.7596×
Mar 31, 2025	-7.7916×
Dec 31, 2024	0.2815×
Sep 30, 2024	-1.8801×
Jun 30, 2024	-1.3351×
Mar 31, 2024	-2.5485×
Dec 31, 2023	0.1646×
Sep 30, 2023	1.5616×
Jun 30, 2023	-3.0717×
Mar 31, 2023	-3.2372×
Dec 31, 2022	-1.3515×
Sep 30, 2022	-3.9059×
Jun 30, 2022	0×
Mar 31, 2022	0×
Dec 31, 2021	0×
Sep 30, 2021	0×
Jun 30, 2021	0×
Mar 31, 2021	0×
Dec 31, 2020	0×
Sep 30, 2020	0×
Jun 30, 2020	0×
Mar 31, 2020	0×
Dec 31, 2019	0×
Sep 30, 2019	0×
Jun 30, 2019	0×
Mar 31, 2019	0×
Dec 31, 2018	-81.0363×
Mar 31, 2018	0×
Dec 31, 2017	1,903.4662×
Mar 31, 2017	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.